Cannara Biotech Inc.

C$2.09As of Sun 8 Nov 2026, 12:00 UTC
TSX:LOVEHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR 0.57%
Div yield —
ROE 9.68%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.32
PE TTM 19.01
TSR TTM 22.22%
Mkt cap C$206.3M
ROIC 8.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.49
19.04%
(21.35%)
Buy 12|3|3|8|1
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.03
0.03
0.03
0.03
15.07%
22.78%
6.82%
2.20%
Revenue$M
22.07
22.15
23.03
23.14
6.44%
6.62%
7.11%
10.39%
Peers (US$146.0M)
Cap (US$)
PE
145.5M
—
141.7M
20.72x
124.8M
1.968x
Capital
TTM
5Y
10Y
Leveragex
1.657
0.217
0.226
EBIT/Intx
1.045
0.195
0.225
Own earn%
(2.51)
(73.15)
(67.48)
Sh yield%
9.37
36.61
41.39
Owners
Insiders/Inst%
6.75
32.46
Short interest%
3.59
SBC / revenue%
4.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
12–16
$1 testx
—
Incr. ROIC%
0